449P Randomized phase II study comparing pathological responses of resected colorectal cancer metastases (CRCM) after bevacizumab (BEV) with FOLFOX or FOLFIRI (BEV-ONCO trial)
| Autor: | Baldin, P., Beniuga, G., Jouret-Mourin, A., Demolin, G., Roland, S., D'Hondt, L.A., Vergauwe, P., Vandaele, D., Mailleux, M., Sinapi, I., De Cuyper, A., Bletard, N., Massart, B., Delos, M., Castella, M-L., van Maanen, A., Carrasco, J., van den Eynde, M. |
|---|---|
| Zdroj: | In Annals of Oncology September 2020 31 Supplement 4:S433-S433 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|